TrialSignal
Clinical trial intelligence report
Clinical Study Evaluating the Efficacy and Safety of Nitazoxanide in Patients With Metastatic Colorectal Cancer
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT06049901
Status
UNKNOWN
Phase
Phase 3
Sponsor
Tanta University
Executive brief
Investment-Ready Snapshot
This clinical trial, sponsored by Tanta University, aims to evaluate the efficacy and safety of nitazoxanide in patients with metastatic colorectal cancer. The study involves 60 participants, divided into two groups: one receiving standard chemotherapy and the other receiving chemotherapy plus nitazoxanide.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT06049901
Indication
Metastatic Colorectal Cancer
Modality
small molecule
Target
Metastatic Colorectal Cancer
Intervention
Nitazoxanide
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.